Pfizer's $6.7 Billion Bet Could Be About to Pay Off Big Time

Pfizer's $6.7 Billion Bet Could Be About to Pay Off Big Time

Source: 
Motley Fool
snippet: 
  • Pfizer's $6.7 billion acquisition of Arena closed in March and is already bearing fruit.
  • Pfizer recently reported positive results from two phase 3 studies of Arena's etrasimod.
  • Etrasimod has blockbuster potential if approved.